국가: 캐나다
언어: 영어
출처: Health Canada
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
SANIS HEALTH INC
N02AJ13
TRAMADOL AND PARACETAMOL
325MG; 37.5MG
TABLET
ACETAMINOPHEN 325MG; TRAMADOL HYDROCHLORIDE 37.5MG
ORAL
100
Narcotic (CDSA I)
OPIATE AGONISTS
Active ingredient group (AIG) number: 0250601001; AHFS:
CANCELLED POST MARKET
2020-12-16
Page 1 of 64 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR TRAMADOL/ACET tramadol hydrochloride and acetaminophen tablets, USP 37.5 mg tramadol hydrochloride/325 mg acetaminophen Centrally Acting Analgesic SANIS HEALTH INC. Date of Revision: 1 President’s Choice Circle November 27, 2018 Brampton, Ontario L6Y 5S5 SUBMISSION CONTROL NUMBER: 221806 Page 2 of 64 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ............................................ 3 SUMMARY PRODUCT INFORMATION ........................................................... 3 INDICATIONS AND CLINICAL USE ................................................................ 3 CONTRAINDICATIONS .................................................................................. 4 WARNINGS AND PRECAUTIONS .................................................................... 4 ADVERSE REACTIONS ................................................................................. 17 DRUG INTERACTIONS ................................................................................. 21 DOSAGE AND ADMINISTRATION ................................................................ 25 OVERDOSAGE ............................................................................................. 27 ACTION AND CLINICAL PHARMACOLOGY ................................................ 29 STORAGE AND STABILITY .......................................................................... 35 SPECIAL HANDLING INSTRUCTIONS ....................................................... 35 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................... 36 PART II: SCIENTIFIC INFORMATION ................................................................. 37 PHARMACEUTICAL INFORMATION ............................................................ 37 CLINICAL TRIALS ........................................................................................ 38 DETAILED PHARMACOLOGY ...................................................................... 42 TOXICOLOGY................ 전체 문서 읽기